Brent Kinder

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
    Brent W Kinder
    Department of Medicine, University of California School of Medicine, San Francisco, California, USA
    Am J Respir Crit Care Med 176:691-7. 2007
  2. ncbi Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis
    Brent Kinder
    Division of Pulmonary Critical Care and Sleep Medicine, The University of Cincinnati School of Medicine, Cincinnati, Ohio 45267 0564, USA
    Lymphat Res Biol 8:71-9. 2010
  3. ncbi Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function
    Brent W Kinder
    Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0564, USA
    Lung 188:143-9. 2010
  4. ncbi Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis
    Brent W Kinder
    University of Cincinnati College of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, 231 Albert Sabin Way, ML 0564, Cincinnati, OH 45267, USA
    Chest 135:1557-63. 2009
  5. ncbi Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis
    Brent W Kinder
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Respir Med 104:578-83. 2010
  6. ncbi Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effective
    Jared T Hagaman
    Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    Am J Respir Crit Care Med 181:1376-82. 2010
  7. ncbi Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis
    Jared T Hagaman
    Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, 231 Albert Sabin Way ML 0564, Cincinnati, OH 45267, USA
    Lung 188:125-32. 2010
  8. ncbi Efficacy and safety of sirolimus in lymphangioleiomyomatosis
    Francis X McCormack
    University of Cincinnati, Cincinnati, OH, USA
    N Engl J Med 364:1595-606. 2011
  9. ncbi Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases
    Lisa R Young
    Division of Pulmonary Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Chest 138:674-81. 2010
  10. ncbi Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus
    Brent W Kinder
    Division of Rheumatology, University of California San Francisco, 374 Parnassus Avenue, San Francisco, CA 94143, USA
    Arthritis Rheum 56:2679-86. 2007

Detail Information

Publications13

  1. ncbi Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
    Brent W Kinder
    Department of Medicine, University of California School of Medicine, San Francisco, California, USA
    Am J Respir Crit Care Med 176:691-7. 2007
    ....
  2. ncbi Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis
    Brent Kinder
    Division of Pulmonary Critical Care and Sleep Medicine, The University of Cincinnati School of Medicine, Cincinnati, Ohio 45267 0564, USA
    Lymphat Res Biol 8:71-9. 2010
    ....
  3. ncbi Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function
    Brent W Kinder
    Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0564, USA
    Lung 188:143-9. 2010
    ..These findings demonstrate the clinical importance of identifying UCTD in patients presenting with an "idiopathic" interstitial pneumonia...
  4. ncbi Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis
    Brent W Kinder
    University of Cincinnati College of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, 231 Albert Sabin Way, ML 0564, Cincinnati, OH 45267, USA
    Chest 135:1557-63. 2009
    ..We hypothesized that baseline serum SP-A and SP-D concentrations would be independently associated with mortality among patients with biopsy-proven IPF and would improve a prediction model for mortality...
  5. ncbi Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis
    Brent W Kinder
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Respir Med 104:578-83. 2010
    ..Although barriers, modifiers, and benefits for clinical trial participation in common diseases such as cancer have been studied, we are unaware of such evaluations concerning rare diseases...
  6. ncbi Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effective
    Jared T Hagaman
    Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    Am J Respir Crit Care Med 181:1376-82. 2010
    ..5 additional pneumothoraces. The diagnosis of LAM is typically delayed until after the second pneumothorax...
  7. ncbi Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis
    Jared T Hagaman
    Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, 231 Albert Sabin Way ML 0564, Cincinnati, OH 45267, USA
    Lung 188:125-32. 2010
    ..quot; At prevalence rates lower than our base case, it was not. TPMT testing before initiating therapy with azathioprine, NAC, and steroids is a cost-effective treatment strategy for IPF...
  8. ncbi Efficacy and safety of sirolimus in lymphangioleiomyomatosis
    Francis X McCormack
    University of Cincinnati, Cincinnati, OH, USA
    N Engl J Med 364:1595-606. 2011
    ..Sirolimus (also called rapamycin) inhibits mTOR and has shown promise in phase 1-2 trials involving patients with LAM...
  9. ncbi Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases
    Lisa R Young
    Division of Pulmonary Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Chest 138:674-81. 2010
    ..The purpose of this study was to determine the prospective diagnostic usefulness of a serologic test for vascular endothelial growth factor-D (VEGF-D), a lymphangiogenic growth factor...
  10. ncbi Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus
    Brent W Kinder
    Division of Rheumatology, University of California San Francisco, 374 Parnassus Avenue, San Francisco, CA 94143, USA
    Arthritis Rheum 56:2679-86. 2007
    ....
  11. ncbi Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis
    Brent W Kinder
    Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Chest 133:226-32. 2008
    ..We hypothesized that baseline BAL fluid cell count differential (ie, elevated levels of neutrophils and eosinophils, or reduced levels of lymphocytes) would predict higher mortality among persons with IPF...
  12. ncbi Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases
    Jared T Hagaman
    Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine and Cincinnati Veteran s Affairs Medical Center, Cincinnati, OH, USA
    Chest 139:353-60. 2011
    ....
  13. ncbi Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease
    Brent W Kinder
    Am J Respir Crit Care Med 177:1292-3; author reply 1293. 2008